Interventions for cognitive deficits in patients with a brain tumor: An update

Expert Review of Anticancer Therapy

Volumn 10, Issue 11, 2010, Pages 1779-1795

  Gehring, Karin ^a   Aaronson, Neil K ^b   Taphoorn, Martin J ^c,d   Sitskoorn, Margriet M ^a  

^a TILBURG UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

brain tumor; cognitive deficits; cognitive rehabilitation; intervention; neuropsychological impairment

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; ARMODAFINIL; BEVACIZUMAB; CARMUSTINE; CHOLINESTERASE INHIBITOR; DONEPEZIL; LEVOTHYROXINE; LIOTHYRONINE; LITHIUM; MEMANTINE; METHYLPHENIDATE; MODAFINIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PSYCHOSTIMULANT AGENT;

ADD ON THERAPY; ALZHEIMER DISEASE; ANXIETY DISORDER; BEHAVIOR THERAPY; BRAIN LYMPHOMA; BRAIN METASTASIS; BRAIN RADIATION; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; COGNITIVE DEFECT; COGNITIVE THERAPY; DEPRESSION; DISEASE COURSE; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; FOLLOW UP; HUMAN; HYPERBARIC OXYGEN; MULTIINFARCT DEMENTIA; MULTIMODALITY CANCER THERAPY; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION NECROSIS; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CARE; REVIEW; SEIZURE; TREATMENT OUTCOME; TREATMENT PLANNING; WHOLE BRAIN RADIATION THERAPY;

BRAIN NEOPLASMS; COGNITION DISORDERS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78649233180     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.10.163     Document Type: Review

References (113)

1. Tucha O, Smely C, Preier M, Lange KW. Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 47(2), 324-333 (2000).
2. Meyers CA, Brown PD. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J. Clin. Oncol. 24(8), 1305-1309 (2006).
3. Laack NN, Brown PD, Ivnik RJ et al. Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. Int. J. Radiat. Oncol. Biol. Phys. 63(4), 1175-1183 (2005).
4. Klein M, Taphoorn MJ, Heimans JJ et al. Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J. Clin. Oncol. 19(20), 4037-4047 (2001).
5. Meyers CA, Smith JA, Bezjak A et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized Phase III trial. J. Clin. Oncol. 22(1), 157-165 (2004).
6. van Nieuwenhuizen D, Klein M, Stalpers LJ et al. Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients. J. Neurooncol. 84(3), 271-278 (2007).
7. Taphoorn MJ, Schiphorst AK, Snoek FJ et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann. Neurol. 36(1), 48-54 (1994).
8. Hahn CA, Dunn RH, Logue PE et al. Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 55(4), 992-999 (2003).
9. Weitzner MA, Meyers CA. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psychooncology 6(3), 169-177 (1997).
10. Aoyama H, Tago M, Kato N et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int. J. Radiat. Oncol. Biol. Phys. 68(5), 1388-1395 (2007).
11. Taphoorn MJ, Klein M. Cognitive defcits in adult patients with brain tumours. Lancet Neurol. 3(3), 159-168 (2004).
12. Rozental JM, Levine RL, Nickles RJ, Dobkin JA, Hanson JM. Cerebral diaschisis in patients with malignant glioma. J. Neurooncol. 8(2), 153-161 (1990).
13. Otte A, Roelcke U, von Ammon K et al. Crossed cerebellar diaschisis and brain tumor biochemistry studied with positron emission tomography, [18F] fluorodeoxyglucose and [11C] methionine. J. Neurol. Sci. 156(1), 73-77 (1998).
14. Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P. Mood and cognitive side effects of interferon-a therapy. Semin. Oncol. 25 (1 Suppl. 1), 39-47 (1998).
15. Correa DD, DeAngelis LM, Shi W et al Cognitive functions in low-grade gliomas: disease and treatment effects. J. Neurooncol. 81(2), 175-184 (2007).
16. Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury Int. J. Radiat. Oncol. Biol. Phys. 6(9), 1215-1228 (1980).
17. Sloan AE, Arnold SM, St Clair WH, Regine WF. Brain injury: current management and investigations. Semin. Radiat. Oncol. 13(3), 309-321 (2003).
18. Monje ML, Mizumatsu S, Fike JR, Palmer TD. Irradiation induces neural precursorcell dysfunction. Nat. Med. 8(9), 955-962 (2002).
19. Monje ML, Vogel H, Masek M et al. Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies. Ann. Neurol. 62(5), 515-520 (2007).
20. Dietrich J, Monje M, Wefel J, Meyers C. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy Oncologist 13(12), 1285-1295 (2008). • Explains the novel concepts of the cranial imaging abnormalities and the cellbiological consequences underlying chemotherapy-and radiation therapyassociated nervous system toxicity, and in particular, cognitive dysfunction.
21. Noble M, Dietrich J. Intersections between neurobiology and oncology: tumor origin, treatment and repair of treatmentassociated damage. Trends Neurosci. 25(2), 103-107 (2002).
22. Welzel G, Steinvorth S, Wenz F. Cognitive effects of chemotherapy and/or cranial irradiation in adults. Strahlenther. Onkol. 181(3), 141-156 (2005).
23. Klein M, Engelberts NH, Van der Ploeg HM et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann. Neurol. 54(4), 514-520 (2003).
24. Meyers CA. Neurocognitive dysfunction in cancer patients. Oncology (Williston Park, NY) 14(1), 75-79 (2000).
25. Lidstone V, Butters E, Seed PT et al. Symptoms and concerns amongst cancer outpatients: identifying the need for specialist palliative care. Palliat. Med. 17(7), 588-595 (2003).
26. Wen PY, Schiff D, Kesari S et al. Medical management of patients with brain tumors. J. Neurooncol. 80(3), 313-332 (2006).
27. Anderson SI, Taylor R, Whittle IR. Mood disorders in patients after treatment for primary intracranial tumours. Br. J. Neurosurg. 13(5), 480-485 (1999).
28. Anderson SW, Damasio H, Tranel D. Neuropsychological impairments associated with lesions caused by tumor or stroke. Arch. Neurol. 47(4), 397-405 (1990).
29. Scheibel RS, Meyers CA, Levin VA. Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J. Neurooncol. 30(1), 61-69 (1996).
30. Meyers CA, Berger MS, Prados M. Functional outcomes. In: Textbook of Neuro-oncology. Elsevier Saunders, PA, USA, 101-104 (2005).
31. Mukand JA, Blackinton DD, Crincoli MG, Lee JJ, Santos BB. Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am. J. Phys. Med. Rehabil. 80(5), 346-350 (2001).
32. Wilson BA. Memory rehabilitation in brain-injured people. In: Cognitive Neurorehabilitation. Stuss DT, Winocur G, Robertson IH (Eds). Cambridge University Press, NY, USA, 333-346 (2005).
33. Cicerone KD, Dahlberg C, Malec JF et al. Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002. Arch. Phys. Med. Rehabil. 86(8), 1681-1692 (2005).
34. Sitzer DI, Twamley EW, Jeste DV. Cognitive training in Alzheimer's disease: a meta-analysis of the literature. Acta Psychiatr. Scand. 114(2), 75-90 (2006).
35. Engelberts NH, Klein M, Ader HJ et al. The effectiveness of cognitive rehabilitation for attention deficits in focal seizures: a randomized controlled study. Epilepsia 43(6), 587-595 (2002).
36. Sohlberg MM, McLaughlin KA, Pavese A, Heidrich A, Posner MI. Evaluation of attention process training and brain injury education in persons with acquired brain injury. J. Clin. Exp. Neuropsychol. 22(5), 656-676 (2000).
37. Winkens I, Van Heugten CM, Wade DT, Fasotti L. Training patients in time pressure management, a cognitive strategy for mental slowness. Clin. Rehabil. 23(1), 79-90 (2009).
38. Kaschel R, Della Sala S, Fahlböck A, Laaksonen R, Kazen M. Imagery mnemonics for the rehabilitation of memory: a randomised group controlled trial. Neuropsychol. Rehabil. 12(2), 127-153 (2002).
39. Levine B, Robertson IH, Clare L et al. Rehabilitation of executive functioning: an experimental-clinical validation of goal management training. J. Int. Neuropsychol. Soc. 6(3), 299-312 (2000).
40. Gehring K, Sitskoorn MM, Aaronson NK, Taphoorn MJ. Interventions for cognitive defcits in adults with brain tumours. Lancet Neurol. 7(6), 548-560 (2008).
41. Bianchetti A, Ranieri P, Margiotta A, Trabucchi M. Pharmacological treatment of Alzheimer's Disease. Aging Clin. Exp. Res. 18(2), 158-162 (2006).
42. Zec RF, Burkett NR. Nonpharmacological and pharmacological treatment of the cognitive and behavioral symptoms of Alzheimer disease. NeuroRehabilitation 23(5), 425-438 (2008).
43. Duffau H, Capelle L, Denvil D et al. Functional recovery after surgical resection of low grade gliomas in eloquent brain: hypothesis of brain compensation. J. Neurol. Neurosurg. Psychiatr. 74(7), 901-907 (2003).
44. Duffau H. New concepts in surgery of WHO grade II gliomas: functional brain mapping, connectionism and plasticity - a review. J. Neurooncol. 79(1), 77-115 (2006).
45. O'Dell MW, Barr K, Spanier D, Warnick RE. Functional outcome of inpatient rehabilitation in persons with brain tumors. Arch. Phys. Med. Rehabil. 79(12), 1530-1534 (1998).
46. Huang ME, Cifu DX, Keyser-Marcus L. Functional outcomes in patients with brain tumor after inpatient rehabilitation: comparison with traumatic brain injury. Am. J. Phys. Med. Rehabil. 79(4), 327-335 (2000).
47. Huang ME, Cifu DX, Keyser-Marcus L. Functional outcome after brain tumor and acute stroke: a comparative analysis. Arch. Phys. Med. Rehabil. 79(11), 1386-1390 (1998).
48. Gehring K, Sitskoorn MM, Gundy CM et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J. Clin. Oncol. 27(22), 3712-3722 (2009). • Methodological issues encountered in this randomized controlled trial are discussed in the current review.
49. Gondi V, Tome WA, Marsh J et al Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933. Radiother. Oncol. 95(3), 327-331 (2010).
50. Correa DD, Rocco-Donovan M, DeAngelis LM et al. Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy J. Neurooncol 91(3), 315-321 (2009).
51. Butler JM Jr, Case LD, Atkins J et al. A Phase III, double-blind, placebocontrolled prospective randomized clinical trial of d-threo- methylphenidate HCl in brain tumor patients receiving radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 69(5), 1496-1501 (2007).
52. Patwardhan SY, Myszka KA, Collins R, Etzel CJ, Meyers CA, Wefel JS. Assessment of the efficacy of immediate release methylphenidate, sustained release methylphenidate, and modafinil for patients with primary brain tumor. J. Int. Neuropsychol. Soc. 16 (Suppl. 1), 88(2010).
53. Wefel JS, Patwardhan S, Levin VA. Neurocognitive outcomes associated with combined levothyroxine/liothyronine supplementation in hypothyroid patients with primary brain tumors. Neuro-oncology 11(5), 642(2009).
54. Sherer M, Meyers CA, Bergloff P. Efficacy of postacute brain injury rehabilitation for patients with primary malignant brain tumors. Cancer 80(2), 250-257 (1997).
55. Duval J, Coyette F, Seron X. Rehabilitation of the central executive component of working memory: a re-organisation approach applied to a single case. Neuropsychol. Rehabil. 18(4), 430-460 (2008).
56. Locke DE, Cerhan JH, Wu W et al. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumors: a pilot study. J. Support. Oncol. 6(8), 383-391 (2008).
57. Hassler MR, Elandt K, Preusser M et al Neurocognitive training in patients with high-grade glioma: a pilot study. J. Neurooncol. 97(1), 109-115 (2010).
58. Bland JM, Altman DG. Regression towards the mean. Br. Med. J. 308(6942), 1499(1994).
59. Sprangers MA, Schwartz CE. Integrating response shift into healthrelated quality of life research: a theoretical model. Soc. Sci. Med. 48(11), 1507-1515 (1999).
60. Kolb B. Synaptic plasticity and the organization of behaviour after early and late brain injury Can. J. Exp. Psychol 53(1), 62-76 (1999).
61. Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS. Neuropsychological Assessment. Oxford University Press, NY, USA (2004).
62. Bruera E, Driver L, Barnes EA et al Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J. Clin. Oncol. 21(23), 4439-4443 (2003).
63. Bruera E, Valero V, Driver L et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J. Clin. Oncol 24(13), 2073-2078 (2006). • Illustrates the importance of inclusion of a placebo-controlled group in trials that evaluate symptomatic outcomes.
64. Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method of minimization for allocation to clinical trials. A review. Control. Clin. Trials 23(6), 662-674 (2002).
65. Altman DG, Bland JM. Treatment allocation by minimisation. Br. Med. J. 330(7495), 843(2005).
66. Treasure T, MacRae KD. Minimisation: the platinum standard for trials? Randomisation doesn't guarantee similarity of groups; minimisation does. Br. Med. J. 317(7155), 362-363 (1998).
67. Bergquist T, Gehl C, Mandrekar J et al The effect of internet-based cognitive rehabilitation in persons with memory impairments after severe traumatic brain injury. Brain Inj. 23(10), 790-799 (2009).
68. Bergquist TF, Thompson K, Gehl C, Munoz Pineda J. Satisfaction ratings after receiving internet-based cognitive rehabilitation in persons with memory impairments after severe acquired brain injury. Telemed. J. E. Health 16(4), 417-423 (2010).
69. Andersson G. Using the internet to provide cognitive behaviour therapy. Behav. Res. Ther. 47(3), 175-180 (2009).
70. Ouimet LA, Stewart A, Collins B, Schindler D, Bielajew C. Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models. J. Clin. Exp. Neuropsychol. 31(1), 73-89 (2009).
71. Maassen GH, Bossema E, Brand N. Reliable change and practice effects: outcomes of various indices compared. J. Clin. Exp. Neuropsychol. 31(3), 339-352 (2009).
72. Evans C, Margison F, Barkham M. The contribution of reliable and clinically significant change methods to evidencebased mental health. Evid. Based Ment. Health 1(3), 70-72 (1998).
73. Collie A, Darby DG, Falleti MG, Silbert BS, Maruff P. Determining the extent of cognitive change after coronary surgery: a review of statistical procedures. Ann. Thorac. Surg. 73(6), 2005-2011 (2002).
74. Copay AG, Subach BR, Glassman SD, Polly DW Jr, Schuler TC. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J. 7(5), 541-546 (2007).
75. Sawrie SM, Martin R, Kuzniecky R et al. Subjective versus objective memory change after temporal lobe epilepsy surgery. Neurology 53(7), 1511-1517 (1999).
76. Cull A, Hay C, Love SB et al. What do cancer patients mean when they complain of concentration and memory problems? Br. J. Cancer 74(10), 1674-1679 (1996).
77. Hermelink K, Untch M, Lux MP et al. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 109(9), 1905-1913 (2007).
78. Schagen SB, Boogerd W, Muller MJ et al. Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Oncol. 47(1), 63-70 (2008).
79. Klein M, Reijneveld JC, Heimans JJ. Subjective ratings vs. objective measurement of cognitive function: in regard to Van Beek et al. (Int. J. Radiat. Oncol. Biol. Phys. 2007;68:986-991).
80. Int. J. Radiat. Oncol. Biol. Phys. 70(3), 961-962 (2008).
81. Middleton LS, Denney DR, Lynch SG, Parmenter B. The relationship between perceived and objective cognitive functioning in multiple sclerosis. Arch. Clin. Neuropsychol. 21(5), 487-494 (2006).
82. Hall KE, Isaac CL, Harris P. Memory complaints in epilepsy: an accurate reflection of memory impairment or an indicator of poor adjustment? A review of the literature. Clin. Psychol. Rev. 29(4), 354-367 (2009).
83. Chaytor N, Schmitter-Edgecombe M. The ecological validity of neuropsychological tests: a review of the literature on everyday cognitive skills. Neuropsychol. Rev. 13(4), 181-197 (2003). • Provides a theoretical discussion of the ecological validity of neuropsychological tests and comprehensive review of the research on this subject.
84. Benedict RH, Cox D, Thompson LL et al. Reliable screening for neuropsychological impairment in multiple sclerosis. Mult. Scler. 10(6), 675-678 (2004).
85. Folstein MF, Robins LN, Helzer JE. The mini-mental state examination. Arch. Gen. Psychiatr. 40(7), 812(1983).
86. Meyers CA, Wefel JS. The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J. Clin. Oncol. 21(19), 3557-3558 (2003).
87. Willer B, Ottenbacher KJ, Coad ML. The community integration questionnaire. A comparative examination. Am. J. Phys. Med. Rehabil. 73(2), 103-111 (1994).
88. Wilson BA. Long-term prognosis of patients with severe memory disorders. Neuropsychol. Rehabil. 1(2), 117-134 (1991).
89. Berg IJ, Koning-Haanstra M, Deelman BG. Long-term effects of memory rehabilitation: a controlled study. Neuropsychol. Rehabil. 1(2), 97-111 (1991).
90. Gray JM, Robertson I, Pentland B, Anderson S. Microcomputer-based attentional retraining after brain damage: a randomised group controlled trial. Neuropsychol. Rehabil. 2(2), 97-115 (1992).
91. Winkens I, Van Heugten CM, Wade DT, Habets EJ, Fasotti L. Efficacy of time pressure management in stroke patients with slowed information processing: a randomized controlled trial. Arch. Phys. Med. Rehabil. 90(10), 1672-1679 (2009).
92. Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE. The importance of placebo effects in pain treatment and research. JAMA 271(20), 1609-1614 (1994).
93. Ernst E, Resch KL. Concept of true and perceived placebo effects. Br. Med. J. 311(7004), 551-553 (1995).
94. Vickers AJ, de Craen AJ. Why use placebos in clinical trials? A narrative review of the methodological literature. J. Clin. Epidemiol. 53(2), 157-161 (2000).
95. O'Shaughnessy JA, Vukelja SJ, Holmes FA et al. Feasibility of quantifying the effects of epoetin a therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy. Clin. Breast Cancer 5(6), 439-446 (2005).
96. Mar. Fan HG, Clemons M, Xu W et al. A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer 16(6), 577-583 (2008).
97. Iconomou G, Koutras A, Karaivazoglou K et al. Effect of epoetin a therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy. Eur. J. Cancer Care (Engl.) 17(6), 535-541 (2008).
98. Kohli S, Fisher SG, Tra Y et al. The effect of modafinil on cognitive function in breast cancer survivors. Cancer 115(12), 2605-2616 (2009).
99. Lundorff LE, Jonsson BH, Sjogren P. Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial. Palliat. Med. 23(8), 731-738 (2009).
100. Blackhall L, Petroni G, Shu J, Baum L, Farace E. A pilot study evaluating the safety and efficacy of modafnal for cancer-related fatigue. J. Palliat. Med. 12(5), 433-439 (2009).
101. Rossi S, Rossini PM. TMS in cognitive plasticity and the potential for rehabilitation. Trends Cogn. Sci. 8(6), 273-279 (2004).
102. Thut G, Pascual-Leone A. A review of combined TMS-EEG studies to characterize lasting effects of repetitive TMS and assess their usefulness in cognitive and clinical neuroscience. Brain Topogr. 22(4), 219-232 (2010).
103. Heyn P, Abreu BC, Ottenbacher KJ. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch. Phys. Med. Rehabil. 85(10), 1694-1704 (2004).
104. Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L. Physical activity and enhanced ftness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst. Rev. 3, CD005381 (2008).
105. van Uffelen JG, Chin APMJ, Hopman-Rock M, van Mechelen W. The effects of exercise on cognition in older adults with and without cognitive decline: a systematic review. Clin. J. Sport Med. 18(6), 486-500 (2008).
106. Spirduso WW, Clifford P. Replication of age and physical activity effects on reaction and movement time. J. Gerontol. 33(1), 26-30 (1978).
107. Dustman R, Emmerson R, Shearer D. Physical activity, age and cognitive neuropsychological function. J. Aging Phys. Act. 2, 143-181 (1994).
108. Hillman CH, Erickson KI, Kramer AF. Be smart, exercise your heart: exercise effects on brain and cognition. Nat. Rev. Neurosci. 9(1), 58-65 (2008). • Examines the positive effects of aerobic physical activity on cognition and brain function at the molecular, cellular, systems and behavioral levels.
109. Colcombe SJ, Erickson KI, Scalf PE et al. Aerobic exercise training increases brain volume in aging humans. J. Gerontol. A Biol. Sci. Med. Sci. 61(11), 1166-1170 (2006).
110. Cotman CW, Berchtold NC, Christie LA. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci. 30(9), 464-472 (2007).
111. Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst. Rev. 2, CD006145 (2008).
112. Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G. Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J. Clin. Oncol. 23(16), 3830-3842 (2005).
113. Courneya KS, Sellar CM, Stevinson C et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J. Clin. Oncol. 27(27), 4605-4612 (2009).